C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids

More topics under "C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids" (173,078)
C07H 1 - Processes for the preparation of sugar derivatives (12,374)
C07H 11 - Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof (1,722)
C07H 13 - Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids (4,753)
C07H 15 - Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals (17,975)
C07H 17 - Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals (11,681)
C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
C07H 23 - Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin b12 (1,716)
C07H 3 - Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms (5,762)
C07H 5 - Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium (3,671)
C07H 7 - Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond (2,294)
C07H 9 - Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical (1,178)
C07H 99 - Subject matter not provided for in other groups of this subclass (52)

Patents for C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids (1,168)
02/2011
02/03/2011	US20110027883 Rna interference mediating small rna molecules
01/2011
01/27/2011	US20110020234 Rna interference mediating small rna molecules
01/20/2011	US20110014123 RNA interference mediating small RNA molecules
12/2010
12/23/2010	US20100324268 Multi-oligomeric or multi--polymeric compositions comprising labeled moieties and binding partners
12/23/2010	US20100324122 Modulation of sglt2 expression
12/16/2010	US20100316703 Rna interference mediating small rna molecules
12/09/2010	US20100311189 Novel Receptor Nucleic Acids and Polypeptides
11/2010
11/18/2010	US20100292456 Rna interference mediating small rna molecules
11/16/2010	CA2422622C Novel baff-r nucleic acids and polypeptides
10/2010
10/19/2010	US7816328 such as 3-(4-Ethylbenzyl)-5-( beta -D-glucopyranosyl)-1H-indole, used for for treating diabetes, Syndrome X, or associated symptoms selected from obesity, nephropathy, neuropathy, retinopathy, atherosclerosis, polycystic ovarian syndrome, hypertension, ischemia, stroke and cardiovascula disorders
09/2010
09/23/2010	US20100240103 Oligonucleotides labeled with a plurality of fluorophores
08/2010
08/25/2010	EP1385857B1 Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
07/2010
07/20/2010	US7759061 2′-nitrobenzyl-modified ribonucleotides
05/2010
05/25/2010	CA2361079C Method for deprotecting oligonucleotides
05/19/2010	EP2186897A1 An improved method for synthesising templated molecules
05/18/2010	US7718374 Probes for continuous monitoring of replication; solid phase synthesis; distinguishing in a sample between wild-type, mutant and heterozygous target polynucleotides
05/04/2010	US7709220 Methods of monitoring treatment of BAFF-R related disease
04/2010
04/20/2010	CA2410579C Methods and compositions for treating flaviviruses and pestiviruses
04/15/2010	US20100092388 Anthracycline Derivatives
04/01/2010	US20100081705 Methods for slowing familial als disease progression
03/2010
03/25/2010	US20100075920 Small molecule stimulators of neuronal growth
03/09/2010	CA2525851C N,n-dialkylpolyhydroxyalklamines
02/2010
02/24/2010	CN101654673A Rna interference mediating small rna molecules
02/24/2010	CN101654672A Rna interference mediating small rna molecules
02/23/2010	US7667024 Oligonucleotides labeled with a plurality of fluorophores
02/10/2010	CN101643789A RNA interference mediating small RNA molecules
02/09/2010	CA2466358C Method for the production of desclarithromycin, and intermediate products
01/2010
01/14/2010	US20100010207 Rna interference mediating small rna molecules
01/07/2010	US20100004160 Substituted fused heterocyclic c-glycosides
12/2009
12/29/2009	US7638503 Small molecule stimulators of neuronal growth
12/29/2009	US7638327 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with expression of B-cells and immunoglobulins); treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/24/2009	US20090317513 Amylose and Amylopectin Derivatives
12/22/2009	US7635677 polypeptides related to a receptor to BAFF (a B-cell activating factor belonging to the Tumor Necrosis Factor family, which is associated with theexpression of B-cells and immunoglobulins); this receptor can be employed in the treatment of cancers, lymphomas, autoimmune diseases related to B-cells
12/15/2009	US7632930 Oligosaccharide derivative
12/02/2009	EP1309726B1 Rna sequence-specific mediators of rna interference
11/2009
11/25/2009	EP1268509B1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
11/24/2009	US7622455 Methods for slowing familial ALS disease progression
11/24/2009	CA2443774C Pharmaceutical dopamine glycoconjugate compositions and methods of their preparation
11/17/2009	CA2588495C The utility of uridine nucleosides in the treatment of cachexia
11/11/2009	EP1451203B1 3-beta-d-ribofuranosylthiazolo(4,5-delta)pyridimine nucleosides and uses thereof
10/2009
10/21/2009	EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/15/2009	US20090258374 Multisignal Labeling Reagents, and Processes and Uses Therefor
10/06/2009	US7598373 Process for the production of 2-C-methyl-D-ribonolactone
09/2009
09/16/2009	EP1149109B1 Method for deprotecting oligonucleotides
09/02/2009	CN101519449A Modified transferrin fusion proteins
08/2009
08/19/2009	EP1485393B1 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives
08/19/2009	CN100528888C Novel anticonvulsant derivative salts
08/19/2009	CN100528887C N,N-dialkyl polyhydroxy alkylamines
08/13/2009	US20090203049 Beta integrin gene and protein
08/05/2009	CN100523215C RNA interference mediating small RNA molecules
08/04/2009	US7569549 Crystallizing in water-miscible solvent, water, and mineral/organic acid
07/2009
07/23/2009	US20090186843 RNA sequence-specific mediators of RNA interference
07/14/2009	US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy
06/2009
06/23/2009	US7550279 Amylose and amylopectin derivatives
06/18/2009	US20090155174 RNA Interference Mediating Small RNA Molecules
06/17/2009	EP1390378B1 Pharmaceutically active uridine esters
06/04/2009	US20090143232 Method for synthesising templated molecules
05/2009
05/12/2009	CA2141430C Nucleic acid sequence amplification
04/2009
04/23/2009	US20090105162 Substituted fused heterocyclic c-glycosides
04/16/2009	DE19520398B4 Magnetisches Pigment Magnetic pigment
04/07/2009	US7514551 Multisignal labeling reagents, and processes and uses therefor
04/02/2009	US20090087922 Single nucleotide polymorphism analysis of highly polymorphic target sequences
03/2009
03/31/2009	US7511133 Sulfonamido derivatives with a conserved ethyl uronamide group;1-deoxy-1-[6-[[[[4-[N-(benzyl)aminosulfonyl]phenyl]amino]-carbonyl]amino]-9H-purin-9-yl]-N-ethyl- beta -D-ribofuranuronamide or derivatives; anticarcinogenic, antiinflammatory, antiischemic, antiepileptic, and hypertensive agents
02/2009
02/25/2009	EP2028278A1 RNA sequence-specific mediators of RNA interference
02/18/2009	CN101367851A Oligosaccharide derivative
02/12/2009	US20090042749 N,N-Dialkylpolyhydroxyalkylamines
02/11/2009	CN100460417C Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the DNA polymerase
02/03/2009	CA2440504C Magnetic pigment
01/2009
01/27/2009	US7482330 3-(4-Ethylbenzyl)-5-( beta -D-glucopyranosyl)-1H-indole; antidiabetic agents; insulin resistance
01/15/2009	US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis
11/2008
11/27/2008	US20080293665 Purine Nucleotide Derivatives
11/25/2008	CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
11/19/2008	EP1487978B1 An improved method for synthesising templated molecules
11/12/2008	EP1648909A4 Thioaptamers enable discovery of physiological pathways and new therapeutic strategies
10/2008
10/30/2008	US20080269147 Used in targeting specific mRNAs for degradation in mammalian cells where use of long dsRNAs to elicit RNAi is usually not practical, presumably because of the deleterious effects of the interferon response; autoimmune disease; tumor-associated gene
10/23/2008	US20080261208 For DNA sequencing
09/2008
09/10/2008	EP1967592A1 Method of improving the efficiency of polynucleotide sequencing
09/10/2008	EP1753774B1 2"-nitrobenzyl-modified ribonucleotides
09/10/2008	CN101260130A Methods of producing C-aryl glucoside SGLT2 inhibitors
09/03/2008	EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer
09/02/2008	CA2278402C Process for selective oxidation of primary alcohols of oligosaccharides
08/2008
08/26/2008	US7417034 Pharmaceutically active uridine esters
08/26/2008	CA2361614C Compositions for treating inflammatory response
08/26/2008	CA2312021C Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis
08/19/2008	US7413854 Method for synthesising templated molecules
08/14/2008	US20080194503 Antisense Modulation of P38 Mitogen Activated Protein Kinase Expression
08/14/2008	US20080194495 1-amino-2,3-dihydroxy-5-hydroxymethyl-cyclopent-4-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction
08/13/2008	CN101239090A Pharmaceutical compositions having appetite suppressant activity
08/13/2008	CN101239089A Pharmaceutical compositions having appetite suppressant activity
07/2008
07/09/2008	CN101218396A Paper pigment, process for producing a paper product and paper product
07/08/2008	US7396826 prophylaxis/therapy of diabetes, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative and neuropathic diseases, neuropathic pain, polyneuropathy using e.g. Octadeca-6,9,12-trienoic acid 5' -(2,4-dioxo-3,4-dihydro-2H-pyrimidine-1-yl)-3',4 dihydroxy-tetrahydrofuran-2'-yl methyl ester
06/2008
06/26/2008	US20080153766 Non-insulin dependent diabetes mellitus; lowers hepatic fatty degeneration; improving liver function by reducing alanine transaminase and aspartate transaminase levels
06/25/2008	EP1670928A4 Single nucleotide polymorphism analysis of highly polymorphic target sequences
06/12/2008	US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis
06/05/2008	US20080132461 Introducing RNA which targets the mRNA of the gene for degradation into the cell or organism; maintaining the cell or organism, maintaining the cell or organism under conditions under which degradation of the mRNA occurs
06/04/2008	CN100391963C Methods of producing C-aryl glucoside SGLT2 inhibitors
05/2008
05/28/2008	EP1585529A4 Process for the production of 2'-branched nucleosides
05/28/2008	CN100390153C Intermediate for producing novel pyrazine derivatives
05/22/2008	US20080119645 Amidites and Methods of Rna Synthesis
05/20/2008	US7375213 inhibitors of sodium dependent glucose transporters found in the intestine and kidney (SGLT2), and more particularly to a process of producing such compounds, for example dapagliflozin

1 2 3 4 5 6 7 8 9 10 11 12